Skip to Content Facebook Feature Image

Thailand BOI Approves Hyundai Mobility's Project to Assemble BEV Electric Cars and Batteries

Business

Thailand BOI Approves Hyundai Mobility's Project to Assemble BEV Electric Cars and Batteries
Business

Business

Thailand BOI Approves Hyundai Mobility's Project to Assemble BEV Electric Cars and Batteries

2024-08-07 16:21 Last Updated At:16:45

BANGKOK, Aug. 7, 2024 /PRNewswire/ -- The Thailand Board of Investment (BOI) today approved investment promotion applications worth a combined 1 billion baht (USD28 million) by Hyundai Mobility Manufacturing (Thailand) Co., Ltd., a unit of Korea's Hyundai Motor Company, to start in 2026 the local assembly of battery electric vehicles (BEV) and the batteries that power them.

The Hyundai project is placed under the second phase of Thailand's plan to become a production hub for electric vehicles, known as the EV 3.5 package, which aims to promote investment in manufacturing covering the entire EV industry ecosystem, from cars to batteries, key parts, and charging stations. As part of the EV 3.5 package, which covers a period of 4 years (2024-2027), the government provides incentives to manufacturers as well as subsidies to consumers purchasing EVs.

"Hyundai's entry in Thailand's EV sector is a very positive development, confirming the attractiveness of Thailand as both a manufacturing base and an important market," said Mr. Narit Therdsteerasukdi, Secretary General of the BOI. "Thailand's strong existing supply chain will allow Hyundai to source not less than a third of the raw materials and parts it needs from within Thailand, thus supporting the local industry."  

The operations will be conducted with Thonburi Automotive Assembly Plant Co., Ltd. as strategic business partner.

The facility will also assemble an equal amount of EV batteries.

Under its 30@30 policy, Thailand expects EVs to represent at least 30% of the total motor vehicle production in the country by the year 2030. Thailand is the largest automotive production hub in Southeast Asia, and ranks in the top 10 in the world. So far, 18 manufacturers from China, Japan and Europe have either started making EVs in Thailand or announced they will begin over the next two years.

The BOI has already approved projects with a total investment value of over 80 billion baht in the EV supply chain.

According to the Global EV Outlook 2024 published by the IEA, in the first quarter of 2024, electric car sales around the world grew by around 25% compared with the first quarter of 2023. EV sales could reach around 17 million in 2024, accounting for more than one in five cars sold worldwide.

For more information, please contact:
Thailand Board of Investment
Tel. +66 (0) 2553 8111
Website: www.boi.go.th
YouTube: Think Asia, Invest Thailand

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Thailand BOI Approves Hyundai Mobility's Project to Assemble BEV Electric Cars and Batteries

Thailand BOI Approves Hyundai Mobility's Project to Assemble BEV Electric Cars and Batteries

SEOUL, South Korea, Sept. 26, 2026 /PRNewswire/ -- MAYPHARM, a global aesthetic and cosmeceutical company, has announced the upcoming launch of HYALMASS AQUATOX, introducing a new multi-active formulation designed to respond to the rapidly evolving demands of the global aesthetic market.

Rather than relying on a single trending ingredient, HYALMASS AQUATOX brings together five high-interest active ingredients — PDRN, Exosomes, Botulinum Peptide, GHK-Cu, and Succinic Acid — in one advanced aesthetic formulation.

Five Powerful Actives. One Advanced Formula.

Botulinum Peptide — designed to support a smoother, more refined skin appearance
GHK-Cu — a copper peptide widely studied for skin conditioning and regeneration-related applications
Succinic Acid — recognized for its role in skin revitalization and antioxidant-related activity
PDRN — associated with skin regeneration and recovery
Exosomes — increasingly recognized for their role in advanced skin rejuvenation approaches

By combining these highly sought-after ingredients, HYALMASS AQUATOX aims to address the growing global demand for multifunctional, ingredient-driven aesthetic solutions.

A New Chapter for the HYALMASS Portfolio

The launch follows the growing international interest in HYALMASS AQUA EXOSOME, strengthening MAYPHARM's expanding presence in the global aesthetic market.

As demand for advanced skin rejuvenation products continues to develop, the market has also seen an increasing number of products adopting similar ingredient concepts, visual identities, and positioning. MAYPHARM therefore emphasizes the importance of product authenticity and authorized distribution when purchasing HYALMASS products.

Distributors, aesthetic professionals, and customers are encouraged to verify the original manufacturer, authorized supply channel, packaging, and official product information before purchasing or using HYALMASS products.

Innovation That Moves With the Market

With HYALMASS AQUATOX, MAYPHARM continues to expand its portfolio around emerging aesthetic trends while combining multiple high-interest actives into a single product concept.

Five actives. One formula. A new direction for advanced skin care.

HYALMASS AQUATOX — Coming Soon.

Choose the Original. Choose MAYPHARM.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market

MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market

MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market

MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market

Recommended Articles